Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12297693rdf:typepubmed:Citationlld:pubmed
pubmed-article:12297693lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C0009325lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C2330894lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C0017243lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C0146337lld:lifeskim
pubmed-article:12297693lifeskim:mentionsumls-concept:C1140999lld:lifeskim
pubmed-article:12297693pubmed:issue4lld:pubmed
pubmed-article:12297693pubmed:dateCreated2002-9-25lld:pubmed
pubmed-article:12297693pubmed:abstractTextThe efficiency of tranilast for the treatment of proliferative vitreoretinopathy (PVR) was investigated in vitro. A tetrazolium-based colorimetric assay showed that the 300-microM concentration of tranilast inhibited proliferation of bovine retinal pigment epithelial (RPE) cells and rabbit dermal fibroblasts with no toxicity. The contraction of collagen gels embedded with these cells was evaluated in the cultures. Compared with the gel incubated with minimal essential medium and 0.35% bovine serum albumin and/or fetal calf serum, tranilast inhibited gel contraction. Enzyme-linked immunosorbent assay revealed that a 300-microM concentration of tranilast inhibited transforming growth factor-beta(1) (TGF-beta(1)) secretion significantly (p < 0.01). These results suggest that tranilast may inhibit the proliferation of RPE cells and fibroblasts and contraction of intraocular fibrous membranes by suppressing TGF-beta(1) secretion from these cells with a potential to treat PVR.lld:pubmed
pubmed-article:12297693pubmed:languageenglld:pubmed
pubmed-article:12297693pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12297693pubmed:citationSubsetIMlld:pubmed
pubmed-article:12297693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12297693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12297693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12297693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12297693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12297693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12297693pubmed:statusMEDLINElld:pubmed
pubmed-article:12297693pubmed:issn0030-3747lld:pubmed
pubmed-article:12297693pubmed:authorpubmed-author:HondaYoshihit...lld:pubmed
pubmed-article:12297693pubmed:authorpubmed-author:TabataYasuhik...lld:pubmed
pubmed-article:12297693pubmed:authorpubmed-author:KimuraHideyaHlld:pubmed
pubmed-article:12297693pubmed:authorpubmed-author:MiyamotoHidek...lld:pubmed
pubmed-article:12297693pubmed:authorpubmed-author:OguraYuichiro...lld:pubmed
pubmed-article:12297693pubmed:authorpubmed-author:DongJinJlld:pubmed
pubmed-article:12297693pubmed:authorpubmed-author:YasukawaTsuto...lld:pubmed
pubmed-article:12297693pubmed:copyrightInfoCopyright 2002 S. Karger AG, Basellld:pubmed
pubmed-article:12297693pubmed:issnTypePrintlld:pubmed
pubmed-article:12297693pubmed:volume34lld:pubmed
pubmed-article:12297693pubmed:ownerNLMlld:pubmed
pubmed-article:12297693pubmed:authorsCompleteYlld:pubmed
pubmed-article:12297693pubmed:pagination206-12lld:pubmed
pubmed-article:12297693pubmed:dateRevised2005-12-15lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:meshHeadingpubmed-meshheading:12297693...lld:pubmed
pubmed-article:12297693pubmed:articleTitleEffect of tranilast on proliferation, collagen gel contraction, and transforming growth factor beta secretion of retinal pigment epithelial cells and fibroblasts.lld:pubmed
pubmed-article:12297693pubmed:affiliationUniversity Eye Hospital Leipzig, Germany.lld:pubmed
pubmed-article:12297693pubmed:publicationTypeJournal Articlelld:pubmed